Ridgewood Investments LLC has filed a Form 13F-HR report disclosing its equity holdings as of September 30, 2026. The filing lists 217 distinct positions held by the firm, with a total equity value of $271,337,300.
The portfolio includes a mix of large-cap technology, healthcare, and consumer staples companies. Major holdings include Berkshire Hathaway Inc. Class B, which is listed with 53,852 shares, and Microsoft Corporation with 7,427 shares. Other notable positions include Apple Inc. with 2,250 shares, NVIDIA Corporation with 15,464 shares, and Eli Lilly & Co. with 455 shares.
The filing also details significant positions in healthcare companies such as Merck & Co. Inc. (8,238 shares), Pfizer Inc. (28,873 shares), and Novo-Nordisk A/S (24,970 shares). Additionally, Ridgewood holds substantial stakes in consumer goods companies like Procter & Gamble Co. and Coca-Cola Company, as well as various exchange-traded funds tracking broad market indices and bond markets.
